Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
DUBLIN, April 26, 2012 /PRNewswire/ --
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces results for the three months to March 31, 2012.
Financial Highlights Q1 2012(1)
$1,107
Product sales million +24%
$1,172
Total revenues million +21%
Non GAAP operating income $362 million +18%
US GAAP operating income $295 million +11%
Non GAAP diluted earnings per ADS ...
Stunning Advancements in Weight Loss Surgery
LOS ANGELES, April 24, 2012 /PRNewswire/ -- Bariatric surgery is not just about losing weight. The most advanced procedures available today, from gastric sleeve surgery to gastric bypass and the Lap Band, offer dramatic weight loss results, but another benefit that gets less attention is the potential effect on certain co-morbidities like hypertension and diabetes.
US Fat Replacers Industry
NEW YORK, April 17, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
US Fat Replacers Industry
This report analyzes the US market for Fat Replacers in Thousand Metric Tons and US$ Million by the following Product Segments: Carbohydrate-Based Fat Replacers (Starch-Based Fat Replacers, & Hydrocolloid-Based Fat Replacers), Protein-Based Fat Replacers, and Fat-Based Fat Replacers.
| Related News: |